The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
The higher the sp rises by 11:00am the greater the oversubscription is likely to be. Currently 10p on the Wrap offer vs 11.5p on the open market, that's already a 15% discount & could go higher yet. May see a surge of late applications for Wrap shares.
Mafuta: "Looks like we'll get what we've subscribed for". Extremely unlikely IMV. I expect the Wrap offer to be massively oversubscribed from the original target, and they won't want to pull any back from the Insti's, so I still expect reduced allocations for II's. Hope you're right though, be good if they could use the Wrap offer to rid themselves of RF completely. As falkirk says, why on earth didn't they do this before instead of allowing RF in?
Smart, it's unlikely one will be able to. Now the oversubscription has been confirmed, IMHO the only way is up from here.
As expected, SAR's army of small investors are giving a very clear message to the company and to the stock market. We're 100% behind you, now go & get the job finished.
Do we call you Robin now or THEPUMA?
To be fair they've been allocated the shares if they wait 3 years. They haven't dipped into their pockets.
And the other 5.9%? Ignore it if you wish, I actually think this is good news for PXS going forward.
Over 13 million tonnes of coal exported from Port of Baltimore in 2022 apparently. Not sure if this will feed through to the POC worldwide?
1. Cyclical nature of the business.
2. Inflation/high interest rates.
3. Sector weakness in general.
Welcome comrade.
I've had my moments with him too goldeninvestor, but I actually admire the guy. He's put his money where his mouth is and always been up front about his buys, however grim they look with hindsight. He'll even admit that he's down a huge chunk. Rather him than these "I invested yesterday" merchants who appear following good news.
"On 27 March 2024 the Company learned that DSM Venturing BV's current shareholding is 130,923,358 shares, being 5.90% of the Company's existing issued share capital, and after the issue of the 45,123,732 New Provexis Shares DSM Venturing BV will hold 176,047,090 shares, which will be 7.78% of the Company's enlarged issued share capital.".
How else would you interpret that?
DSM are building a position here. Could be the precursor to a full-blown bid? Certainly one to keep an eye on.
Susi, do you have any idea how a junior biotech works? I'd say you don't , based on that post.
Closes at 12:00 noon on Tuesday 2nd April.
On a Bank Holiday weekend.
Interesting challenge for the brokers.
Surfie: "If (and ONLY if) you were a new investor this may be worth a punt at some point today but LTH's are f*cked. "
I'm a long-term holder & I assure you I'm not f*cked. I get pleasure from making money for myself and my family, which enables me to support some of the charities that have a particular significance to us, including CRUK. You, on the other hand, get pleasure from seeing other people's misery, but you yourself don't benefit from it. So, enjoy your day, I look forward to having mine.
I notice John Reader isn't participating in the fundraise. They've always presented a united front in the past when raising funds. This suggests he's not happy about something - maybe he lobbied for an earlier raise when things would have been much less painful, or he didn't want to get on board with RF perhaps? Either way, it's not good. We need them to show a united front at this stage, more than ever.
Unbelievable. Just unbelievable.
Out of interest, where does it say the managed wind-down is subject to shareholder approval?
Think I'll wait for the first set of numbers from the combined group before leaping to any conclusions. Things could be very positive going forward IMHO.
On the contrary PUMA, there are many PI's ready & willing to support a cash call from the company, should it be required. I think you'll find we're a very powerful lobby, if push comes to shove.